The Archive · 32,142 records
Source documents — page 83 of 129
Source documents, page 83 of 129: records 20,501–20,750 of 32,142, titles N–O.
Browse by source, program, docket, document type or year.
Records 20,501–20,750 of 32,142
N
- Notice of Withdrawal of Counsel Christine P. Sun — East Bay Sanctuary Covenant v. Barr (Case 4:19-cv-04073-JST, Document 86)Withdrawal of Christine P. Sun as plaintiffs' counsel in East Bay Sanctuary Covenant v.…
- Notice of Withdrawal of Counsel — East Bay Sanctuary Covenant v. Trump (N.D. Cal.)Notice of withdrawal of counsel for amici NCLR et al. in East Bay Sanctuary Covenant v.…
- Notice of Withdrawal of Counsel — Jonathan K. Ogata — East Bay Sanctuary Covenant v. Barr (Case 4:19-cv-04073-JST, Document 135)Notice of withdrawal of counsel for Proposed Plaintiff-Intervenors, East Bay Sanctuary…
- Notice of Withdrawal of Jennifer Chang Newell as Counsel — East Bay Sanctuary Covenant v. Trump (Document 123)Notice withdrawing Jennifer Chang Newell as Plaintiffs' counsel, East Bay Sanctuary…
- Notice of Withdrawal of Jennifer Chang Newell as Counsel — East Bay Sanctuary Covenant v. Trump (Document 124)Notice withdrawing Jennifer Chang Newell as Plaintiffs' counsel, East Bay Sanctuary…
- Notice of Withdrawal of Julie Veroff as Counsel — East Bay Sanctuary Covenant v. Trump (Document 130)Notice of withdrawal of Julie Veroff as plaintiffs' counsel in East Bay Sanctuary…
- Notice of Withdrawal of Motion for Relief from the Automatic Stay — In re Panthera Enterprises, LLC, Case 2:19-bk-00787, Doc. 385 (Filed 07/21/21)WVEDA's notice withdrawing its stay-relief motion in In re Panthera Enterprises, LLC, No.…
- Notice of Withdrawal of Preliminary Injunction Motion — America's Frontline Doctors v. Xavier Becerra, Case No. 2:21-cv-702-CLMNotice withdrawing preliminary injunction motion ECF 15, America's Frontline Doctors v.…
- Notice Of Withdrawal Of The Limited ObjectionInsperity withdraws its limited objection to assuming the service agreement with the…
- Notice of Withdrawal — In re Vyaire Medical, Inc (Dkt. 675)Notice of Withdrawal — In re Vyaire Medical, Inc (Dkt. 675): notice of withdrawal. Full text and…
- Notice of Withdrawal/Addition of Counsel for Amicus — East Bay Sanctuary Covenant v. Trump (Case 4:18-cv-06810-JST, Document 104)Notice of withdrawal and addition of counsel for amicus Public Citizen, Inc., East Bay…
- Notice of Zoom Hearing on Bernstein-Burkley's Final Application for Compensation, December 17, 2020 — In re Panthera Enterprises, LLC, Case 2:19-bk-00787, Doc. 250 (Filed 11/15/20)Notice of a December 17, 2020 hearing in the Chapter 7 case of Panthera Enterprises, LLC,…
- Notice of Zoom Hearing Set for April 8, 2021 — In re Panthera Enterprises, LLC, Case 2:19-bk-00787, Doc. 293 (Filed 02/27/21)Notice of hearing, Doc 293 in In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr.…
- Notice of Zoom Hearing Set for February 25, 2021 — In re Panthera Enterprises, LLC, Case 2:19-bk-00787, Doc. 274 (Filed 01/15/21)Hearing notice, In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr. N.D.W. Va.),…
- Notice of Zoom Hearing Set for January 28, 2021 — In re Panthera Enterprises, LLC, Case 2:19-bk-00787, Doc. 260 (Filed 12/19/20)Notice of hearing, Doc 260, In re Panthera Enterprises, No. 2:19-bk-00787 (Bankr. N.D. W.…
- Notice On Motion To Compromise Objections Of Trustee AndNotice On Motion To Compromise Objections Of Trustee And: source document dated March 6, 2021.…
- Notice re Breach of Fiduciary Duty Claim — In re BofA Unemployment Benefits LitigationNotice re Breach of Fiduciary Duty Claim — In re BofA Unemployment Benefits Litigation: source…
- Notice of Motion of Debtors to File Under Seal the Fee Letters for the DIP Facilities (Case 24-11217-BLS, Doc 107)Notice of Motion of Debtors to File Under Seal the Fee Letters for the DIP Facilities (Case 24-11217-BLS, Doc 107): source document dated June 10, 2024, criminal prosecutions…
- Notice re_ Motion to Seal Retention AppsNotice re_ Motion to Seal Retention Apps: source document dated June 10, 2024, criminal…
- Notice Regarding Deadline to Obligate Reallocated Funds — Emergency Rental Assistance (July 29, 2022)Ppr Int Deadline To Obligate Reallocated Era1 Funds public court record for Ppr Int…
- Notice Regarding Entry of a Plea of Guilty — United States v. Samuel Powell, No. 21-10048 (Dkt. 18, C.D. Ill.)Notice Regarding Entry of a Plea of Guilty — United States v. Samuel Powell, No. 21-10048…
- Notice Regarding Unobligated ERA1 FundsPpr Int Notice Regarding Unobligated Era1 Funds — Notice Regarding Unobligated ERA1 Funds.
- Notice Regarding Update to ERA FAQ 46Ppr Int Notice To Era2 Grantees — Notice Regarding Update to ERA FAQ 46.
- Notice That the Transcript Is Available to Case Participants Only (Sealed) — AirBoss Defense Group v. United States, Case 1:24-cv-00365, Doc. 64 (Filed 06/24/24)Notice of sealed transcript filing, Doc. 64, AirBoss Defense Group v. United States, No.…
- Notice That the Transcript Is Available to Case Participants Only (Sealed) — AirBoss Defense Group v. United States, Case 1:24-cv-00365, Doc. 85 (Filed 09/04/24)Sealed transcript notice, Doc. 85, AirBoss Defense Group v. United States, No. 24-365C…
- Notice to All Creditors — Application for Compensation and Reimbursement of Expenses for Bernstein-Burkley, P.C. (Doc 240)Negative notice, Doc 240 in In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr.…
- Notice to All Creditors — Application for Compensation for Trustee Expenses for Aaron C. Amore, Trustee Chapter 7 (Doc 457)Negative notice, In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr. N.D.W. Va.),…
- Notice to All Creditors — Application for Compensation Jack Lantzy, Panthera Enterprises, LLC (Doc 362)Negative notice, Doc 362 in In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr.…
- Notice to All Creditors — Application for Compensation Kelly T. Smith, CPA of the firm of Smith, Elliot, Kearns & Company, LLC (Doc 262)Motion public court record for Notice to All Creditors — Application for Compensation…
- Notice to All Creditors — Application for Compensation, Aaron C. Amore, Trustee's Attorney, Panthera Enterprises, LLC (Doc 430)Motion public court record for Notice to All Creditors — Application for Compensation,…
- Notice to All Creditors — Notice of Intent to Abandon Promissory Note, Panthera Enterprises, LLC (Doc 472)Negative notice, Doc 472 in In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr.…
- Notice to All Creditors — Second Interim Application for Compensation for Accountant John P. Lantzy, Panthera Enterprises, LLC (Doc 406)Negative notice, Doc 406, In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr. N.D.…
- Notice to All Creditors — Second Motion to Extend Exclusivity Period for Filing a Chapter 11 Plan, Panthera Enterprises, LLC (Doc 103)Negative notice, Doc 103 in In re Panthera Enterprises, No. 2:19−bk−00787 (Bankr. N.D. W.…
- Notice to All Parties in Interest — Motion for Relief from Stay, Panthera Enterprises, LLC, Case No. 2:19-bk-00787 (Doc 153)Clerk's notice, May 28, 2020, of a motion for stay relief to pursue insurance, In re…
- Notice to Contract Parties of Potentially Assumed and Assigned Executory Contracts and Unexpired Leases (Doc 505-1, Case No. 24-11217)Contract — Notice to Contract Parties of Potentially Assumed and Assigned Executory…
- Notice to Court Regarding Status of Ancillary Forfeiture Proceeding — No. 24-mc-50425 (Dkt. 2, E.D. Mich.)Notice to Court Regarding Status of Ancillary Forfeiture Proceeding — No. 24-mc-50425…
- Notice to Lenders that SBA has Informed Eligible Borrowers of Assistance Available under Section 1112 of the CARES ActSBA Information Notice 5000-20086, January 27, 2021: SBA has written to 7(a), 504 and…
- Notice to Parties in Interest — Amended Motion to Withdraw as Counsel of Record for Panthera Training, LLC (Doc 453)Negative notice, In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr. N.D.W. Va.),…
- Notice to Parties in Interest — Application for Compensation for Accountant Jack Lantzy, Panthera Enterprises, LLC (Doc 465)Negative notice, Doc 465 in In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr.…
- Notice to Parties in Interest — Application for Compensation for Kelly T. Smith, Accountant, Period: 10/4/2021 to 11/4/2021 (Doc 411)Motion public court record for Notice to Parties in Interest — Application for…
- Notice to Parties in Interest — Application to Employ Aaron C. Amore as Attorney, Panthera Enterprises, LLC (Doc 207)Negative notice, Doc 207, In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr. N.D.…
- Notice to Parties in Interest — Application to Employ Bernstein-Burkley, P.C. as Counsel to Debtor (Doc 18)Motion public court record for Notice to Parties in Interest — Application to Employ…
- Notice to Parties in Interest — Application to Employ John P. Lantzy as Accountant, Panthera Enterprises, LLC (Doc 212)Negative notice, Doc 212, In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr. N.D.…
- Notice to Parties in Interest — Application to Employ Kelly T. Smith, CPA, CGMA, MBA as Accountant (Doc 225)Negative notice in In re Panthera Enterprises, No. 2:19-bk-00787 (Bankr. N.D. W. Va.),…
- Notice to Parties in Interest — First Motion for Award of Fees Against Bernstein-Burkley, P.C. (Doc 266)Negative notice, Doc 266, In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Bankr. N.D.…
- Notice to Parties in Interest — In re Panthera Enterprises, LLC (Bankr. N.D. W. Va.)Doc 412, In re Panthera Enterprises, No. 2:19-bk-00787 (Bankr. N.D. W. Va.): notice of an…
- Notice to Parties in Interest — Third Interim Fee Application for Compensation for John "Jack" P. Lantzy, CPA (Doc 437)Motion public court record for Notice to Parties in Interest — Third Interim Fee…
- Notice to Parties in Interest — Third Motion to Extend Exclusivity Period for Filing a Chapter 11 Plan, Panthera Enterprises, LLC (Doc 139)Negative notice, Doc 139, In re Panthera Enterprises, No. 2:19−bk−00787 (Bankr. N.D. W.…
- Notice to Retained Criminal Defense Attorneys — No. 4:23-cr-00029 (Dkt. 5, S.D. Ga.)Notice to retained defense counsel, USA vs. Jacqueline Somesso, No. 4:23-cr-00029 (S.D.…
- Notice Trustee’S Motion For AuthorizationNotice of trustee's motion for first interim distribution, In re Panthera Enterprises,…
- Notice Trustee’s Motion to Compromise and Sell Estate’sNotice Trustee’s Motion to Compromise and Sell Estate’s: source document. Full text and citation…
- Notice Trustee’s Motion to Compromise and Sell Estate’s — In re Panthera Enterprises, LLC, No. 2:19-bk-00787 (Chapter 7)Notice Trustee’s Motion — In re Panthera Enters. Panthera Enterprises, LLC, No.…: source document.…
- Notice Withdrawing ECF No. 269 — Brooks v. Thomson Reuters CorporationNotice Withdrawing ECF No. 269 — Brooks v. Thomson Reuters Corporation: source document dated…
- Notice — In re Kabbage, Inc. d/b/a KServicing (Case No. 22-10951, Doc 379)Kabbage Chapter 11 Notice of Staffing Report, Doc 379 filed 12/27/22, of Phoenix…
- Notice — Training and Employment 6-21, State Workforce Agencies (September 15, 2021)DOL TEN 6-21 (September 15, 2021): how states access identity proofing services through…
- Notice, § 26 [“Please check www.PlaidSettlement.com, or Judge Donna M. Ryu’s CalendarNotice, § 26 [“Please check www.PlaidSettlement.com, or Judge Donna M. Ryu’s Calendar: source…
- Notice: Lapse in Appropriations (SBA file date: April 16 ver 2)Archived source document: Notice: Lapse in Appropriations (SBA file date: April 16 ver 2).
- Notice: Lapse in Appropriations (SBA file date: April 24 ver 1)Archived source document: Notice: Lapse in Appropriations (SBA file date: April 24 ver 1).
- Notification of Docket Entry — No. 1:23-cr-00097 (Dkt. 72, N.D. Ill.)Notification of Docket Entry — No. 1:23-cr-00097 (Dkt. 72, N.D. Ill.).
- Notitie — Economische analyse steunpakket 2020 (Centraal Planbureau, september 2021)CPB Notitie, Economische analyse steunpakket 2020 (Centraal Planbureau, september 2021):…
- NOVAVAX INC Form 4 (Aug. 16, 2022) — Kelly James PatrickNOVAVAX INC [NVAX] Form 4: EVP, CFO and Treasurer James Patrick Kelly reports 2,367…
- NOVAVAX INC Form 4 (Aug. 19, 2021)NOVAVAX INC [NVAX] Form 4: John Trizzino granted 1,965 restricted stock units on…
- NOVAVAX INC Form 4 (Aug. 19, 2022) — Trizzino JohnNOVAVAX INC [NVAX] Form 4: John Trizzino reports 655 shares from vested RSUs and 317…
- NOVAVAX INC Form 4 (Aug. 24, 2021)NOVAVAX INC [NVAX] Form 4: John A. Herrmann III reports 2,000 shares from RSUs owned by…
- NOVAVAX INC Form 4 (Aug. 24, 2022) — Herrmann John A IIINOVAVAX INC [NVAX] Form 4: John A. Herrmann III reports spouse's 2,000 RSUs vesting and…
- NOVAVAX INC Form 4 (Aug. 26, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised options and 2,754 stock…
- NOVAVAX INC Form 4 (Aug. 31, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn sold common stock on 08/31/2021 under a Rule…
- NOVAVAX INC Form 4 (Dec. 1, 2021)NOVAVAX INC [NVAX] Form 4: John A. Herrmann III exercised a 5,000-share option on…
- NOVAVAX INC Form 4 (Dec. 13, 2021)NOVAVAX INC [NVAX] Form 4: director Richard Douglas exercised an option for 1,500 shares…
- NOVAVAX INC Form 4 (Dec. 14, 2021) — Erck Stanley CNOVAVAX INC [NVAX] Form 4: Stanley C. Erck acquired 6,967 shares on vesting RSUs on…
- NOVAVAX INC Form 4 (Dec. 14, 2021) — Glenn Gregory MNOVAVAX INC [NVAX] Form 4: Gregory M. Glenn reports RSU vesting on 12/14/2021 and option…
- NOVAVAX INC Form 4 (Dec. 14, 2021) — Herrmann John A IIINOVAVAX INC [NVAX] Form 4: John A. Herrmann III reports 2,100 RSU shares acquired on…
- NOVAVAX INC Form 4 (Dec. 14, 2021) — Trizzino JohnNOVAVAX INC [NVAX] Form 4: John Trizzino reports 1,600 shares acquired on vesting RSUs on…
- NOVAVAX INC Form 4 (Dec. 14, 2022) — Erck Stanley CNOVAVAX INC [NVAX] Form 4: Stanley C. Erck received 6,966 shares from vested RSUs on…
- NOVAVAX INC Form 4 (Dec. 14, 2022) — Glenn Gregory MNOVAVAX INC [NVAX] Form 4: President, R&D Gregory M. Glenn received 3,100 shares from…
- NOVAVAX INC Form 4 (Dec. 14, 2022) — Herrmann John A IIINOVAVAX INC [NVAX] Form 4: John A. Herrmann III received 2,100 shares from vested RSUs on…
- NOVAVAX INC Form 4 (Dec. 14, 2022) — Trizzino JohnNOVAVAX INC [NVAX] Form 4: John Trizzino received 1,600 shares from vested RSUs on…
- NOVAVAX INC Form 4 (Dec. 20, 2021)NOVAVAX INC [NVAX] Form 4: John A. Herrmann III exercised and sold 5,000 shares on…
- NOVAVAX INC Form 4 (Dec. 31, 2021)NOVAVAX INC [NVAX] Form 4: director James F. Young exercised an option for 3,750 shares…
- NOVAVAX INC Form 4 (Dec. 7, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised 8,250 options at $19.08 on…
- NOVAVAX INC Form 4 (Jan. 3, 2022)NOVAVAX INC [NVAX] Form 4: John A. Herrmann III exercised a 5,000-share option on…
- NOVAVAX INC Form 4 (July 26, 2021)NOVAVAX INC [NVAX] Form 4: John A. Herrmann III exercised options and sold common stock…
- NOVAVAX INC Form 4 (June 10, 2022) — Alton Gregg HNOVAVAX INC [NVAX] Form 4: director Gregg H. Alton received a 4,600-share option at…
- NOVAVAX INC Form 4 (June 10, 2022) — DOUGLAS RICHARDNOVAVAX INC [NVAX] Form 4: director Richard Douglas reports 3,100 RSUs and an option for…
- NOVAVAX INC Form 4 (June 10, 2022) — MCGLYNN MARGARET GNOVAVAX INC [NVAX] Form 4: director Margaret G. McGlynn received an option for 4,600…
- NOVAVAX INC Form 4 (June 10, 2022) — MOTT DAVID MNOVAVAX INC [NVAX] Form 4: director David M. Mott granted an option for 4,600 shares at…
- NOVAVAX INC Form 4 (June 10, 2022) — YOUNG JAMES FNOVAVAX INC [NVAX] Form 4: director James F. Young granted an option for 6,900 shares at…
- NOVAVAX INC Form 4 (June 16, 2022) — MCMANUS MICHAEL A JRNOVAVAX INC [NVAX] Form 4: vesting of director Michael A. McManus Jr.'s 700 RSUs…
- NOVAVAX INC Form 4 (June 17, 2022) — Alton Gregg HNOVAVAX INC [NVAX] Form 4: director Gregg H. Alton reports 700 RSUs vesting into 700…
- NOVAVAX INC Form 4 (June 17, 2022) — DOUGLAS RICHARDNOVAVAX INC [NVAX] Form 4: director Richard Douglas acquired 700 shares from vested RSUs…
- NOVAVAX INC Form 4 (June 17, 2022) — MCGLYNN MARGARET GNOVAVAX INC [NVAX] Form 4: director Margaret G. McGlynn reports 700 vested RSUs converted…
- NOVAVAX INC Form 4 (June 17, 2022) — MOTT DAVID MNOVAVAX INC [NVAX] Form 4: director David M. Mott received 700 shares from vested RSUs on…
- NOVAVAX INC Form 4 (June 17, 2022) — YOUNG JAMES FNOVAVAX INC [NVAX] Form 4: director James F. Young acquired 1,400 shares from vested RSUs…
- NOVAVAX INC Form 4 (June 25, 2022) — Herrmann John A IIINOVAVAX INC [NVAX] Form 4: EVP, Chief Legal Officer John A. Herrmann III reports 833…
- NOVAVAX INC Form 4 (June 25, 2022) — Trizzino JohnNOVAVAX INC [NVAX] Form 4: EVP, CCO and CBO John Trizzino reports 833 vested RSUs and 278…
- NOVAVAX INC Form 4 (March 10, 2022)NOVAVAX INC [NVAX] Form 4: Stanley C. Erck granted an option for 62,211 shares at $77.77…
- NOVAVAX INC Form 4 (March 10, 2022) — Glenn Gregory MNOVAVAX INC [NVAX] Form 4: Gregory M. Glenn received 18,894 RSUs and an option for 28,341…
- NOVAVAX INC Form 4 (March 10, 2022) — Herrmann John A IIINOVAVAX INC [NVAX] Form 4: John A. Herrmann III granted 13,825 RSUs and an option for…
- NOVAVAX INC Form 4 (March 10, 2022) — Kelly James PatrickNOVAVAX INC [NVAX] Form 4: James Patrick Kelly, EVP, CFO and Treasurer, granted an option…
- NOVAVAX INC Form 4 (March 10, 2022) — Trizzino JohnNOVAVAX INC [NVAX] Form 4: John Trizzino reports 13,825 RSUs and a 20,737-share option at…
- NOVAVAX INC Form 4 (March 31, 2022) — YOUNG JAMES FNOVAVAX INC [NVAX] Form 4: director James F. Young sold 8,945, 3,255 and 300 shares on…
- NOVAVAX INC Form 4 (Nov. 1, 2021)NOVAVAX INC [NVAX] Form 4: John A. Herrmann III exercised a 5,000-share option at $19.08…
- NOVAVAX INC Form 4 (Nov. 15, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised options and sold common stock on…
- NOVAVAX INC Form 4 (Nov. 2, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised an option for 8,250 shares on…
- NOVAVAX INC Form 4 (Nov. 23, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised 8,250 options at $19.08 on…
- NOVAVAX INC Form 4 (Nov. 26, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised 2,083 options and 1,377 stock…
- NOVAVAX INC Form 4 (Nov. 29, 2021)NOVAVAX INC [NVAX] Form 4: John A. Herrmann III exercised and sold 5,000 shares on…
- NOVAVAX INC Form 4 (Nov. 3, 2021)NOVAVAX INC [NVAX] Form 4: John A. Herrmann III exercised an option and sold 5,000 shares…
- NOVAVAX INC Form 4 (Nov. 30, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised 8,250 options on 11/30/2021, owned…
- NOVAVAX INC Form 4 (Nov. 9, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised 8,250 options at $19.08 and sold…
- NOVAVAX INC Form 4 (Oct. 1, 2021) — Erck Stanley CNOVAVAX INC [NVAX] Form 4: Stanley C. Erck exercised options for 14,000 and 35,000 shares…
- NOVAVAX INC Form 4 (Oct. 1, 2021) — Herrmann John A IIINOVAVAX INC [NVAX] Form 4: John A. Herrmann III exercised 5,000 options at $19.08 and…
- NOVAVAX INC Form 4 (Oct. 12, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised 8,250 options at $19.08 on…
- NOVAVAX INC Form 4 (Oct. 15, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised options for 521 and 662 shares and…
- NOVAVAX INC Form 4 (Oct. 19, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised an 8,250-share option on 10/19/2021…
- NOVAVAX INC Form 4 (Oct. 26, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised options and 1,378 stock…
- NOVAVAX INC Form 4 (Oct. 29, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn sold common stock on 10/29/2021 under a Rule…
- NOVAVAX INC Form 4 (Oct. 29, 2022) — Rodgers Richard JNOVAVAX INC [NVAX] Form 4: director Richard J. Rodgers granted an option for 17,095…
- NOVAVAX INC Form 4 (Oct. 4, 2021)NOVAVAX INC [NVAX] Form 4: Stanley C. Erck exercised options for 32,000 and 10,829 shares…
- NOVAVAX INC Form 4 (Oct. 5, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised an option for 8,250 shares at…
- NOVAVAX INC Form 4 (Sept. 1, 2021)NOVAVAX INC [NVAX] Form 4: John A. Herrmann III exercised an option for 5,000 shares at…
- NOVAVAX INC Form 4 (Sept. 13, 2021)NOVAVAX INC [NVAX] Form 4: John Trizzino exercised options for 7,499 shares at $19.08 and…
- NOVAVAX INC Form 4 (Sept. 20, 2021)NOVAVAX INC [NVAX] Form 4: John Trizzino exercised options for 7,500 shares each day and…
- NOVAVAX INC Form 4 (Sept. 23, 2021)NOVAVAX INC [NVAX] Form 4: director David M. Mott reports common stock sales on…
- NOVAVAX INC Form 4 (Sept. 26, 2021) — Erck Stanley CNOVAVAX INC [NVAX] Form 4: Stanley C. Erck, President and CEO, reports 6,546 RSU shares…
- NOVAVAX INC Form 4 (Sept. 26, 2021) — Herrmann John A IIINOVAVAX INC [NVAX] Form 4: John A. Herrmann III reports RSU shares acquired on…
- NOVAVAX INC Form 4 (Sept. 26, 2021) — Trizzino JohnNOVAVAX INC [NVAX] Form 4: John Trizzino acquired 3,537 shares on vesting RSUs on…
- NOVAVAX INC Form 4 (Sept. 26, 2022) — Erck Stanley CNOVAVAX INC [NVAX] Form 4: President and CEO Stanley C. Erck reports 6,546 vested RSUs…
- NOVAVAX INC Form 4 (Sept. 26, 2022) — Herrmann John A IIINOVAVAX INC [NVAX] Form 4: John A. Herrmann III reports vested RSUs of 3,973 (direct) and…
- NOVAVAX INC Form 4 (Sept. 26, 2022) — Trizzino JohnNOVAVAX INC [NVAX] Form 4: John Trizzino reports 3,538 vested RSUs and 1,709 shares…
- NOVAVAX INC Form 4 (Sept. 27, 2021)NOVAVAX INC [NVAX] Form 4: John Trizzino exercised an option for 7,501 shares at $19.08…
- NOVAVAX INC Form 4 (Sept. 28, 2021)NOVAVAX INC [NVAX] Form 4: John Trizzino reports a 7,501-share option exercise and code S…
- NOVAVAX INC Form 4 (Sept. 29, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn exercised 2,083 options and 1,377 stock…
- NOVAVAX INC Form 4 (Sept. 30, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn sold common stock on 09/30/2021 at prices…
- NOVAVAX INC Form 4 — Glenn Gregory M (Aug. 16, 2021)NOVAVAX INC [NVAX] Form 4: Gregory M. Glenn, President, R&D, exercised options and sold…
- NOVAVAX INC Form 4 — Kelly James Patrick (Aug. 16, 2021)NOVAVAX INC [NVAX] Form 4: James Patrick Kelly, EVP, CFO and Treasurer, granted 7,100…
- NOVAVAX, INC. Form 10-K (Dec. 31, 2019)Novavax, Inc. Form 10-K for 2019: NanoFlu and ResVax vaccine candidates, 2019 quarterly…
- NOVAVAX, INC. Form 10-Q (June 30, 2020)Novavax, Inc. Form 10-Q, quarter ended June 30, 2020: total assets 932,227 thousand and…
- NOVAVAX, INC. Form 10-Q (June 30, 2022)Novavax, Inc. Form 10-Q, quarter ended June 30, 2022: three-month revenue 185,925…
- NOVAVAX, INC. Form 10-Q (March 31, 2020)Novavax, Inc. Form 10-Q, quarter ended March 31, 2020: net loss 25,864 thousand, total…
- NOVAVAX, INC. Form 10-Q (March 31, 2022)Novavax, Inc. Form 10-Q, quarter ended March 31, 2022: revenue 703,971 thousand, net…
- NOVAVAX, INC. Form 10-Q (Sept. 30, 2020)Novavax, Inc. Form 10-Q, quarter ended September 30, 2020: three-month revenue 157,024…
- NOVAVAX, INC. Form 10-Q (Sept. 30, 2021)Novavax, Inc. Form 10-Q, quarter ended September 30, 2021: three-month revenue 178,844…
- NOVAVAX, INC. Form 10-Q (Sept. 30, 2022)Novavax, Inc. Form 10-Q, quarter ended September 30, 2022: three-month revenue 734,577…
- NOVAVAX, INC. Form 8-K (April 12, 2021)Novavax, Inc. Form 8-K, April 12, 2021, Item 5.02: Gregory F. Covino resigns as Chief…
- NOVAVAX, INC. Form 8-K (April 20, 2022)Novavax, Inc. Form 8-K, April 20, 2022, Item 7.01: initial results of the…
- NOVAVAX, INC. Form 8-K (April 23, 2021)Novavax, Inc. Form 8-K, April 23, 2021, Item 1.01: Modification No. 7 to the Operation…
- NOVAVAX, INC. Form 8-K (Aug. 10, 2020) — Item 2.02Novavax, Inc. Form 8-K, August 10, 2020, Item 2.02: second quarter 2020 financial results…
- NOVAVAX, INC. Form 8-K (Aug. 10, 2020) — Item 8.01Novavax, Inc. Form 8-K, August 10, 2020, Item 8.01: resale prospectus supplement for…
- NOVAVAX, INC. Form 8-K (Aug. 16, 2021) — Item 1.01Novavax, Inc. Form 8-K, August 16, 2021, Item 1.01: advance purchase agreement with the…
- NOVAVAX, INC. Form 8-K (Aug. 16, 2021) — Item 5.02Novavax, Inc. Form 8-K, August 16, 2021, Item 5.02: James P. Kelly appointed Chief…
- NOVAVAX, INC. Form 8-K (Aug. 5, 2021)Novavax, Inc. Form 8-K, August 5, 2021, Item 2.02: second quarter 2021 financial results…
- NOVAVAX, INC. Form 8-K (Aug. 8, 2022)Novavax, Inc. Form 8-K, August 9, 2022, Item 2.02: second quarter 2022 financial results…
- NOVAVAX, INC. Form 8-K (Dec. 14, 2022)Novavax, Inc. Form 8-K, December 14, 2022, Items 7.01 and 8.01: revenue guidance, UK…
- NOVAVAX, INC. Form 8-K (Dec. 14, 2022) — Item 1.01Novavax, Inc. Form 8-K, December 19, 2022, Items 1.01 and 8.01: common stock offering and…
- NOVAVAX, INC. Form 8-K (Dec. 20, 2021)Novavax, Inc. Form 8-K, December 20, 2021, Item 8.01: European Commission grants…
- NOVAVAX, INC. Form 8-K (Dec. 20, 2022)Novavax, Inc. Form 8-K, December 21, 2022, Item 1.01: completion of the $150 million…
- NOVAVAX, INC. Form 8-K (Dec. 23, 2021)Novavax, Inc. Form 8-K, December 30, 2021, Item 1.01: amendment to the SK bioscience…
- NOVAVAX, INC. Form 8-K (Dec. 23, 2022)Novavax, Inc. Form 8-K, December 28, 2022, Item 1.01: sale of $25.25 million additional…
- NOVAVAX, INC. Form 8-K (Dec. 31, 2020)Novavax, Inc. Form 8-K, December 31, 2020, Item 1.01: advanced purchase agreement with…
- NOVAVAX, INC. Form 8-K (Dec. 5, 2020)Novavax, Inc. Form 8-K, December 5, 2020, Item 5.02: Margaret G. Mcglynn appointed to the…
- NOVAVAX, INC. Form 8-K (Feb. 1, 2022)Novavax, Inc. Form 8-K, February 7, 2022, Item 1.01: Modification No. 13 to the Operation…
- NOVAVAX, INC. Form 8-K (Feb. 10, 2022)Novavax, Inc. Form 8-K, February 10, 2022, Item 7.01: conference call on the pediatric…
- NOVAVAX, INC. Form 8-K (Feb. 12, 2021)Novavax, Inc. Form 8-K, February 12, 2021, Item 1.01: collaboration and license agreement…
- NOVAVAX, INC. Form 8-K (Feb. 24, 2021)Novavax, Inc. Form 8-K, February 24, 2021, Items 1.01 and 2.02: collaboration and license…
- NOVAVAX, INC. Form 8-K (Feb. 28, 2022)Novavax, Inc. Form 8-K, March 1, 2022, Item 2.02: fourth quarter and fiscal year 2021…
- NOVAVAX, INC. Form 8-K (Jan. 10, 2022)Novavax, Inc. Form 8-K, January 10, 2022, Item 7.01: investor presentation at the J.P.…
- NOVAVAX, INC. Form 8-K (Jan. 11, 2021)Novavax, Inc. Form 8-K, January 11, 2021, Item 7.01: investor presentation at the J.P.…
- NOVAVAX, INC. Form 8-K (Jan. 19, 2021)Novavax, Inc. Form 8-K, January 19, 2021, Items 1.01 and 8.01: Canada agreement for 52…
- NOVAVAX, INC. Form 8-K (Jan. 21, 2020)Novavax, Inc. Form 8-K, January 21, 2020, Item 8.01: at-the-market sales agreement with…
- NOVAVAX, INC. Form 8-K (July 30, 2020)Novavax, Inc. Form 8-K, July 30, 2020, Item 1.01: supply and license agreement with Serum…
- NOVAVAX, INC. Form 8-K (July 6, 2020)Novavax, Inc. Form 8-K, July 6, 2020, Item 1.01: Operation Warp Speed agreement for up to…
- NOVAVAX, INC. Form 8-K (July 6, 2022)Novavax, Inc. Form 8-K, July 11, 2022, Item 1.01: Modification No. 14 on the government…
- NOVAVAX, INC. Form 8-K (June 14, 2020)Novavax, Inc. Form 8-K, June 14, 2020, Item 5.02: David M. Mott appointed to the Board of…
- NOVAVAX, INC. Form 8-K (June 14, 2021)Novavax, Inc. Form 8-K, June 14, 2021, Item 8.01: press release announcing PREVENT-19…
- NOVAVAX, INC. Form 8-K (June 15, 2020)Novavax, Inc. Form 8-K, June 15, 2020, Items 1.01, 3.02, 3.03, 5.03, 8.01: $200.0 million…
- NOVAVAX, INC. Form 8-K (June 15, 2021)Novavax, Inc. Form 8-K, June 15, 2021, Item 8.01: at-the-market sales agreement with B.…
- NOVAVAX, INC. Form 8-K (June 16, 2022)Novavax, Inc. Form 8-K, June 21, 2022, Items 5.02 and 5.07: annual meeting vote results…
- NOVAVAX, INC. Form 8-K (June 17, 2021) — Item 5.03Novavax, Inc. Form 8-K, June 17, 2021, Items 5.02 and 5.03: amended change in control…
- NOVAVAX, INC. Form 8-K (June 17, 2021) — Item 5.07Novavax, Inc. Form 8-K, June 17, 2021, Items 5.02 and 5.07: annual meeting results and…
- NOVAVAX, INC. Form 8-K (June 24, 2020)Novavax, Inc. Form 8-K, June 26, 2020, Items 2.03, 5.02, 5.07: CEPI draw of $76.0 million…
- NOVAVAX, INC. Form 8-K (June 8, 2020)Novavax, Inc. Form 8-K, June 8, 2020, Item 1.01: letter contract with the U.S. Department…
- NOVAVAX, INC. Form 8-K (March 11, 2020)Novavax, Inc. Form 8-K, March 11, 2020, Item 2.02: press release on financial results for…
- NOVAVAX, INC. Form 8-K (March 2, 2020)Novavax, Inc. Form 8-K, March 2, 2020, Item 8.01: new at-the-market agreement for up to…
- NOVAVAX, INC. Form 8-K (March 24, 2020)Novavax, Inc. Form 8-K, March 24, 2020, Item 7.01: positive top-line NanoFlu influenza…
- NOVAVAX, INC. Form 8-K (March 5, 2022)Novavax, Inc. Form 8-K, March 7, 2022, Item 5.02: director Rajiv I. Modi resigns from the…
- NOVAVAX, INC. Form 8-K (May 10, 2021)Novavax, Inc. Form 8-K, May 10, 2021, Item 2.02: first quarter 2021 financial results…
- NOVAVAX, INC. Form 8-K (May 11, 2020) — Item 1.01Novavax, Inc. Form 8-K, May 11, 2020, Items 1.01 and 7.01: restated CEPI funding…
- NOVAVAX, INC. Form 8-K (May 11, 2020) — Item 2.02Novavax, Inc. Form 8-K, May 11, 2020, Item 2.02: first quarter 2020 financial results…
- NOVAVAX, INC. Form 8-K (May 13, 2020)Novavax, Inc. Form 8-K, May 13, 2020, Item 7.01: investor presentation on the NVX-CoV2373…
- NOVAVAX, INC. Form 8-K (May 18, 2020)Novavax, Inc. Form 8-K, May 18, 2020, Item 8.01: at-the-market sales agreement with B.…
- NOVAVAX, INC. Form 8-K (May 27, 2020)Novavax, Inc. Form 8-K, May 27, 2020, Items 1.01, 2.01, 7.01: acquisition of Praha…
- NOVAVAX, INC. Form 8-K (May 9, 2022)Novavax, Inc. Form 8-K, May 10, 2022, Item 2.02: first quarter 2022 financial results…
- NOVAVAX, INC. Form 8-K (Nov. 10, 2020)Novavax, Inc. Form 8-K, November 10, 2020, Item 8.01: at-the-market sales agreement with…
- NOVAVAX, INC. Form 8-K (Nov. 18, 2022)Novavax, Inc. Form 8-K, November 21, 2022, Item 1.02: termination of the Gavi Alliance…
- NOVAVAX, INC. Form 8-K (Nov. 4, 2021)Novavax, Inc. Form 8-K, November 5, 2021, Item 2.02: third quarter 2021 financial results…
- NOVAVAX, INC. Form 8-K (Nov. 7, 2020)Novavax, Inc. Form 8-K, November 9, 2020, Items 2.02 and 5.02: Gregory F. Covino…
- NOVAVAX, INC. Form 8-K (Nov. 8, 2022)Novavax, Inc. Form 8-K, November 8, 2022, Item 2.02: third quarter 2022 financial results…
- NOVAVAX, INC. Form 8-K (Oct. 22, 2020)Novavax, Inc. Form 8-K, October 22, 2020, Item 1.01: UK vaccine supply agreement for 60…
- NOVAVAX, INC. Form 8-K (Oct. 26, 2021)Novavax, Inc. Form 8-K, November 1, 2021, Item 1.01: Supply Agreement with Serum…
- NOVAVAX, INC. Form 8-K (Oct. 27, 2021)Novavax, Inc. Form 8-K, October 27, 2021, Item 8.01: rolling submission to the U.K. MHRA…
- NOVAVAX, INC. Form 8-K (Oct. 29, 2022)Novavax, Inc. Form 8-K, November 1, 2022, Item 5.02: Richard J. Rodgers appointed to the…
- NOVAVAX, INC. Form 8-K (Oct. 31, 2020)Novavax, Inc. Form 8-K, October 31, 2020, Item 5.02: Gregg H. Alton appointed to the…
- NOVAVAX, INC. Form 8-K (Sept. 10, 2020)Novavax, Inc. Form 8-K, September 10, 2020, Item 7.01: investor presentation at Citi…
- NOVAVAX, INC. Form 8-K (Sept. 11, 2020)Novavax, Inc. Form 8-K, September 11, 2020, Item 1.01: amendment to Serum Institute of…
- NOVAVAX, INC. Form 8-K (Sept. 30, 2022)Novavax, Inc. Form 8-K, October 6, 2022, Item 1.01: settlement with Fujifilm Diosynth of…
- NOVAVAX, INC. Form 8-K (Sept. 9, 2021)Novavax, Inc. Form 8-K, September 9, 2021, Item 7.01: investor presentation on the…
- Novavax, Inc., Form 10-K, fiscal year ended December 31, 2023Archived source document: Novavax, Inc., Form 10-K, fiscal year ended December 31, 2023.
- Novavax, Inc., Form 8-K (May 10, 2024)Archived source document: Novavax, Inc., Form 8-K (May 10, 2024).
- November Update: COVID-19 Loan GuaranteeSouth African banks report over R50 billion in Covid-19 relief as at 24 October 2020 and…
- NTA Blog: Math Error Part II (Taxpayer Advocate Service)Archived source document: NTA Blog: Math Error Part II (Taxpayer Advocate Service).
- Ntc of Withdrawal of ExsNtc of Withdrawal of Exs: source document dated September 13, 2024, criminal prosecutions…
- Number Go Up: Inside Crypto's Wild Rise and Staggering Fall — Zeke FauxZeke Faux's website: his crypto book Number Go Up, reviews, awards and contacts for…
- Numerated Acquires Fincura to Take the Pain out of Financial Spreading for Business Lenders and Their BorrowersBusiness Wire press release, December 7, 2021: Numerated acquires Fincura Inc., adding…
- Numerated Launches Forgiveness Automation After Partnering with 70+ BanksNumerated expands its platform to automate Paycheck Protection Program forgiveness, after…
- Numerated Receives $15M Series BNumerated announcement of 2019-09-10 that it closed a $15 million Series B investment led…
- Nursing Director Pleads Guilty to Lying to Federal Agents Regarding Production of Fraudulent COVID-19 Vaccine CardsD.S.C. press release, June 23, 2022: nursing director Tammy Hutson McDonald pleads guilty…
- Nursing Home Response to COVID-19 PandemicNursing Home Response to COVID-19 Pandemic: court filing dated January 28, 2021. Full text and…
- NV 16341-01-SP SBA Ofrece Asistencia de Desastres a los Pequeños Negocios de Nevada Impactados Económicamente por Coronavirus (COVID-19)SBA disaster release NV 16341-01-SP (en español), March 17, 2020: COVID-19…
- NV 16341-02 SBA Amends Disaster Declaration: Disaster Assistance Now Available to all Nevada Small Businesses Economically Impacted by the Coronavirus (COVID-19)SBA disaster release NV 16341-02, March 21, 2020: amended declaration makes COVID-19…
- NV 16341-02-SP SBA Modifica la Declaración de Desastre : Asistencia de Desastres en Nevada para los Pequeños Negocios Impactados Económicamente por Coronavirus (COVID-19)SBA disaster release NV 16341-02-SP (en español), March 21, 2020: COVID-19…
- Statewide Per Pupil Funding Amounts (Department of Education file name: NV-FY-23-Maintenance-of-Equity-August-2022.xlsx)Archived source document: Statewide Per Pupil Funding Amounts (Department of Education…
- NY 16346 - La SBA ofrece asistencia en caso de desastre a las pequeñas empresas de New York afectadas económicamente por el Coronavirus (COVID-19)SBA disaster release NY 16346 (en español), March 19, 2020: COVID-19 working-capital…
- NY 16346 - SBA Offers Disaster Assistance to New York Small Businesses Economically Impacted by the Coronavirus (COVID-19)SBA disaster release NY 16346, March 19, 2020: COVID-19 working-capital disaster loans…
- Nydia Velazquez Contributors 2021 - 2022 — Top 20 contributors to Campaign Committee (OpenSecrets)OpenSecrets list of top 20 contributors to Nydia Velazquez's 2021-2022 campaign…
- Nydia Velazquez — Campaign Finance Summary, 2023-2024 Election Cycle (OpenSecrets)Archived source: Nydia Velazquez — Campaign Finance Summary, 2023-2024 Election Cycle…
- Nydia Velazquez — Top Contributors, 2021-2022 Election Cycle (OpenSecrets)Archived source: Nydia Velazquez — Top Contributors, 2021-2022 Election Cycle…
- NYPD Officer Indicted for Grand Larceny in COVID-19 Loan Fraud Scheme (Bronx District Attorney, 16-2026, February 10, 2026)NYPD Officer Indicted for Grand Larceny in COVID-19 Loan Fraud Scheme (Bronx District…
- NYT issues correction after significantly overstating COVID hospitalizations in children (The National Desk)Archived source document: NYT issues correction after significantly overstating COVID…
O
- o Record of pending orderso Record of pending orders: source document dated March 25, 2020, criminal prosecutions…
- O'Fallon Man Pleads Guilty to PPP Loan FraudPress release of April 29, 2021: Jason Spengler of O'Fallon, Illinois, pleaded guilty to…
- Oakland County Sleep Specialists Agree to Pay $763,954.74 to Settle False Claims Act AllegationsU.S. Attorney's Office (E.D. Mich.) press release: Troy Sleep Center and doctors pay…
- Oakland Woman Charged in Million Dollar Scheme to Defraud Pandemic Relief Programs for Struggling BusinessesPress release on the arrest of Christina Burden of Oakland on a bank fraud complaint over…
- Oakland Woman Sentenced To Three Years In Million Dollar Pandemic Relief Fraud — USAO California, NorthernNorthern District of California release, 2022-02-24: Christina Burden sentenced to 36…
- Objection of Airgas Therapeutics to Assumed-Contract Notice — In re Vyaire MedicalObjection of Airgas Therapeutics to Assumed-Contract Notice — In re Vyaire Medical: source…
- Objection of American Express to Joint Motion of Cross River Bank and Customers Bank for anObjection of American Express to Joint Motion of Cross River Bank and Customers Bank for an…
- Objection of Cigna to Assumed-Contract Cure Notice — In re Vyaire MedicalObjection of Cigna to Assumed-Contract Cure Notice — In re Vyaire Medical: source document dated…
- Objection of Cigna to Disclosure Statement — In re Vyaire Medical, Inc.Objection of Cigna to Disclosure Statement — In re Vyaire Medical, Inc.: source document dated…
- Objection of Insperity PEO Services, L.P. to the Assumption of the Service Agreement withObjection of Insperity PEO Services, L.P. to the Assumption of the Service Agreement with: source…
- Objection of Southern California Edison Company to MotionObjection of Southern California Edison Company to Motion: source document dated July 2, 2024.…
- Objection of the Chubb Companies to Cure and Bidding Procedures — In re Vyaire MedicalObjection of the Chubb Companies to Cure and Bidding Procedures — In re Vyaire Medical: source…
- Objection of Trustee to Application for Final Compensation and Reimbursement — In re Panthera Enterprises, LLC (Dkt. 247)Objection of Trustee to Application for Final Compensation and Reimbursement — In re Panthera…
- Objection of Trustee to Proof of Claim No. 5 Filed by the Sheriff of Hardy County — In re Panthera Enterprises, LLC (Dkt. 390.1)Objection of Trustee to Proof of Claim No. 5 Filed by the Sheriff of Hardy County — In re Panthera…
- Objection To Debtor'S Motion To ExtendThis is docket entry 69, WVEDA's 4-page Objection to Debtor's Motion to Extend Time for Debtor to…
- Objection to Findings Concerning Plea Agreement — United States v. Jon M. Hallford, No. 24-cr-00113-NYW (Dkt. 83, D. Colo.)Objection to Findings Concerning Plea Agreement — United States v. Jon M. Hallford, No.…
- Objection to Motion for Approval of Attorneys Fees and Costs — In re Panthera Enterprises, LLCObjection to Motion — In re Panthera Enterprises: document dated February 1, 2021. Full text and…
- Objection to Settlement Agreement and Release of All Claims — U.S. Navy SEALs 1-26 v. Biden (Dkt. 297, N.D. Tex. No. 4:21-cv-01236)Class member Damon Young Turner's objection to the settlement in U.S. Navy SEALs 1-26 v.…
- Objection to the Debtor’s Motion for an Order Approving the Sale of the Debtor’s Real Property — In re Panthera Enterprises, LLC, Case No. 2:19-bk-00787 (Doc 321)Objection by Renick, Betty and Robert Williams to the Trustee's motion to sell Panthera…
- Objection to Wveda Motion for Relief from Automatic Stay — In re Panthera EnterprisesObjection to Wveda Motion for Relief — In re Panthera Enters. Relief from…: objection with…
- Objections and Responses to the Presentence Report — United States v. Jon Michael Hallford, No. 24-cr-00113-NYW (Dkt. 70, D. Colo.)Objections and Responses to the Presentence Report — United States v. Jon Michael…